Report title: Arcoxia is Merck's follow-up to its blockbuster COX-2 antagonist Vioxx
from Business & Industry®
489 word report published Feb NaN, 0Marc

Price $9.95 available for immediate download
Report Overview
 
About Business & Industry®

Source: Marketletter
Geographic Region: North America (NOAX), United States (USAX)
Industry(ies): Pharmaceutical
Free Sample: Click Here to Download
Format:
HTML HTML


Price: $9.95



  Get FREE Research

Sign up here to receive email alerts for FREE Research from Alacra Partners!


  Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.